A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 22, 2022

Primary Completion Date

April 26, 2026

Study Completion Date

May 30, 2026

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG

WST-057 Active

WST-057 Topical Solution

DRUG

Placebo

Matching Placebo Topical Solution

Trial Locations (1)

Levine Cancer Institute, Charlotte

All Listed Sponsors

lead

WinSanTor, Inc

INDUSTRY